Ernexa Therapeutics, Inc. (ERNA)
4.30
+0.14
(+3.24%)
USD |
NASDAQ |
Sep 14, 10:06
Ernexa Therapeutics Market Cap : 5.031M for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.873M |
| September 10, 2026 | 4.703M |
| September 09, 2026 | 4.703M |
| September 08, 2026 | 4.902M |
| September 04, 2026 | 5.043M |
| September 03, 2026 | 5.300M |
| September 02, 2026 | 5.312M |
| September 01, 2026 | 5.090M |
| August 31, 2026 | 5.347M |
| August 28, 2026 | 5.347M |
| August 27, 2026 | 5.54M |
| August 26, 2026 | 5.721M |
| August 25, 2026 | 5.762M |
| August 24, 2026 | 5.891M |
| August 21, 2026 | 5.686M |
| August 20, 2026 | 5.288M |
| August 19, 2026 | 5.183M |
| August 18, 2026 | 4.972M |
| August 17, 2026 | 4.750M |
| August 14, 2026 | 4.996M |
| August 13, 2026 | 5.031M |
| August 12, 2026 | 5.171M |
| August 11, 2026 | 5.136M |
| August 10, 2026 | 5.300M |
| August 07, 2026 | 4.926M |
| Date | Value |
|---|---|
| August 06, 2026 | 5.101M |
| August 05, 2026 | 4.797M |
| August 04, 2026 | 5.171M |
| August 03, 2026 | 4.023M |
| July 31, 2026 | 3.824M |
| July 30, 2026 | 4.046M |
| July 29, 2026 | 3.976M |
| July 28, 2026 | 4.209M |
| July 27, 2026 | 4.571M |
| July 24, 2026 | 4.582M |
| July 23, 2026 | 4.652M |
| July 22, 2026 | 5.189M |
| July 21, 2026 | 5.294M |
| July 20, 2026 | 6.331M |
| July 17, 2026 | 7.486M |
| July 16, 2026 | 8.302M |
| July 15, 2026 | 7.847M |
| July 14, 2026 | 7.066M |
| July 13, 2026 | 6.460M |
| July 10, 2026 | 7.066M |
| July 09, 2026 | 6.914M |
| July 08, 2026 | 6.681M |
| July 07, 2026 | 7.229M |
| July 06, 2026 | 7.509M |
| July 02, 2026 | 7.311M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cerenome, Inc. | 16.37M |
| ACADIA Pharmaceuticals, Inc. | 4.763B |
| Alnylam Pharmaceuticals, Inc. | 33.16B |
| Anika Therapeutics, Inc. | 279.17M |
| Savara, Inc. | 1.093B |
Market Cap Related Metrics
| Price to Book Value | 1.573 |
| Price | 4.30 |
| Earnings Yield | -440.1% |